Your Virtual EEG Department that backs up, not replaces, your team. SEE HOW It Works→

logo corticare
Request A Coverage Review

EEG Services For Clinical Trials

End-to-End EEG Services to Reduce Clinical Trial Risk for Sponsors & CROs

Standardized EEG acquisition across multi-site protocols without variability or drift.

Request an EEG Consultation
Download Product Brochure

EEG Risk in Clinical Trials Doesn’t Start at
Interpretation—It Starts at Acquisition.

In decentralized and multi-site trials, differences in EEG setup, training, and execution introduce variability that compounds over time. This directly impacts endpoint reliability, study timelines, and regulatory confidence.

CortiCare manages the full EEG process for clinical trials — from acquisition and quality oversight through interpretation and data delivery—so EEG remains consistent, controlled, and aligned with protocol requirements.

Proven CNS Trials Experience

  • 18 CNS clinical trials supported since 2019
  • 2,200+ protocol-controlled EEG acquisitions completed
  • Preclinical through Phase I–IV trial experience
  • Multi-site and decentralized trial support
  • Continuous and intermittent EEG monitoring capabilities
  • EEG + PSG (sleep study) integration experience

Clinical & Indication Breadth

  • Pediatric and rare CNS population expertise
  • Experience across:
  • Angelman Syndrome
  • SCN2A Encephalopathy
  • Epilepsy
  • Hypoxic-Ischemic Encephalopathy (HIE)
  • Dementia with Lewy Bodies (DLB)
  • Neuropathy
  • Healthy participant cohorts

Justin Withers

Director-Clinical Trial Services

“Decentralized trials create variability. Our role is to bring structure and control so EEG never becomes the reason a study fails. We built this to give sponsors consistency from acquisition through interpretation.”

Most Trials Do Not Fail Because The Science Is Incorrect.

They fail when execution becomes inconsistent across sites and over time. When EEG is part of the protocol, the primary challenge is not access; it is variability.

  • Inconsistent EEG acquisition across sites
  • Gradual drift in technique and protocol adherence
  • Differences in site training and execution
  • Data that meets minimum requirements but lacks consistency
  • Increased variability in EEG-derived endpoints

For sponsors, this introduces uncertainty in endpoint integrity.

For CROs, it creates avoidable execution risk.

The result is predictable: delays, rework, regulatory scrutiny, and reduced confidence in the data.

CortiCare’s Role: Make EEG a Controlled Variable

CortiCare serves as a dedicated EEG partner for clinical trials, focused specifically on protocol-driven execution. Our model is designed to ensure consistency across all phases of EEG delivery.

We provide:

  • Standardized EEG acquisition across sites
  • Protocol-specific workflows aligned to study requirements
  • Centralized QA, monitoring, and recertification
  • Consistent interpretation and data handling
  • End-to-end coordination from acquisition through delivery

This approach ensures EEG is executed consistently across sites and throughout the duration of the trial.

Proven Expertise

Challenging the Status Quo in Clinical Trials

0 +
Registered EEG Technologists
0 +
Board-certified Epileptologists
0
CNS clinical trials supported since 2019
0 +
Protocol-controlled EEG acquisitions

Trial-Ready EEG Execution Across CNS Protocols

We support EEG-driven and EEG-adjacent protocols across:
  • Epilepsy and seizure disorder trials
  • Sleep and circadian rhythm studies (EEG + PSG)
  • Neurodegenerative disease trials
  • Movement disorder protocols
  • Psychiatric and cognitive research
  • Drug and device trials requiring EEG endpoints
All services are structured around:
  • Protocol requirements
  • Monitoring plans
  • Data integrity expectations
  • Regulatory documentation standards

Execution is aligned to the protocol — not adapted from general clinical workflows.

A Centralized EEG Model Built
for Decentralized Trials

CortiCare enables consistent EEG execution across distributed trial environments.

Standardized across:

  • Sites
  • Staff
  • Time
  • Patient populations

This reduces:

  • Site-to-site variability
  • Execution drift over long trials
  • Dependence on local differences in staffing and experience

The result is a more consistent and reliable EEG dataset across the study.

Sponsor Value:
Protect Endpoint Integrity

EEG can directly influence the quality and reliability of trial endpoints.

CortiCare helps sponsors:

  • Improve consistency in EEG acquisition across sites
  • Reduce variability in EEG-dependent outcomes
  • Maintain confidence in study timelines
  • Support regulatory defensibility of EEG data
  • Reduce the need for intensive internal oversight
Our role is to ensure EEG execution supports, rather than compromises, the integrity of the study.

CRO Value:
Execution Without Instability

EEG is often one of the more variable components of trial execution. CortiCare provides a structured layer of consistency across sites.

We support CRO teams by:
  • Reducing site-level variability and escalations
  • Supporting consistent protocol adherence
  • Minimizing execution drift over time
  • Delivering clean, analysis-ready datasets
This allows CRO teams to maintain focus on broader trial execution without managing EEG-related variability.

Operational Strength That Prevents Drift

Our operational framework includes:

  • Standardized site onboarding and training
  • Centralized QA and recertification programs
  • Protocol-specific acquisition workflows
  • Continuous monitoring of execution consistency
  • Defined escalation and oversight processes
These systems are designed to maintain consistency from study start through completion.

Why CortiCare Is Different in Clinical Trials

  • EEG-focused organization with trial-specific expertise
  • Built around protocol execution, not general clinical workflows
  • Experience in pediatric and rare CNS populations
  • Designed for decentralized and multi-site trial environments
  • Operational model built to reduce variability and drift
Our approach ensures EEG execution aligns with the needs of the protocol across all sites and timepoints.

How It Works

A structured approach designed for consistency and reliability.

Trial EEG
Consultation

Review protocol requirements, EEG endpoints, and execution risks.

Protocol-Specific
EEG Execution Plan

Define standardized acquisition workflows, training, QA, interpretation, and data delivery.

Ongoing Oversight
& Quality Control​

Maintain consistency across sites through centralized monitoring, QA & recertification.

Let's Discuss Your Clinical Trial

EEG Should Never Be the Reason a Trial Fails

CortiCare ensures EEG execution remains consistent and aligned with protocol requirements throughout the study.

Let's Discuss Your Trial
Download Product Brochure

FAQs

What is Clinical Trials EEG?
EEG acquisition and interpretation performed according to protocol requirements, regulatory standards, and endpoint integrity expectations.
Trial EEG requires consistency and standardization across sites and time, rather than adapting to local clinical practices.
No. CortiCare supports site teams through centralized training, QA, and oversight to maintain consistency.
Yes. Our model is designed to support distributed and decentralized trial environments.
Variability in acquisition, protocol drift, inconsistent data quality, endpoint noise, and regulatory risk.